Boswellia appears in joint supplements alongside turmeric and glucosamine, and it has a small but reasonably consistent evidence base.
What is boswellia?
A resin from Boswellia serrata, the Indian frankincense tree, used in Ayurvedic medicine for inflammatory conditions.
The active compounds are boswellic acids, with one called AKBA attracting most research interest.
What do people take it for?
Osteoarthritis, particularly of the knee, and joint stiffness more generally.
It is also taken for inflammatory bowel conditions and asthma, both with much thinner evidence.
What does the research show?
Trials in knee osteoarthritis have reported reductions in pain and improvements in function compared with placebo.
Meta-analyses have described the effects as modest but consistent, with benefit appearing within about four weeks.
Studies have generally been small and several were industry funded, which are the usual limitations in this literature.
How does it work?
Boswellic acids inhibit an enzyme called 5-lipoxygenase, involved in producing inflammatory mediators, which is a different pathway from that targeted by anti-inflammatory drugs.
What dose is used?
Trials have used varying amounts, commonly around 100 to 250 milligrams daily of extracts standardised for AKBA, or larger amounts of less concentrated extracts.
Checking the standardisation matters, since boswellia products differ enormously in concentration.
What are the side effects?
- Stomach upset, nausea and diarrhoea
- Acid reflux in some people
- Skin rash occasionally
Taking boswellia with food reduces the digestive effects for most people.
Who should be careful?
Pregnant and breastfeeding women, where safety has not been established.
Anyone on anti-inflammatory or anticoagulant medication, where interactions have been proposed.
People with inflammatory bowel disease should discuss it with their team rather than self treating.
How does it compare with alternatives?
Exercise and strengthening have substantially better evidence for osteoarthritis than any supplement.
Weight management reduces joint loading meaningfully where relevant.
Topical anti-inflammatories have good evidence for knee and hand osteoarthritis with limited systemic absorption.
Is it worth trying?
Alongside exercise rather than instead of it, boswellia is a reasonable option with better evidence than several better known joint supplements.
Allow four to eight weeks before judging.
What is the summary?
Boswellia is taken for joint pain, has modest supporting trials, works over weeks and should sit alongside exercise rather than replace it.
This article is general information and not medical advice.
Where does it come from?
The resin is tapped from the tree in a similar way to the frankincense used as incense, which is a related species.
Boswellia has been used in Ayurvedic practice for joint and inflammatory complaints for a very long time.
How does it compare with turmeric?
Both are taken for joint pain and both have modest supporting trials, with turmeric having the larger literature.
Some products combine them, which is reasonable provided each is present at a meaningful dose rather than as a token.
What should you check on a label?
The standardisation, usually stated as a percentage of boswellic acids or of AKBA specifically.
Without that figure, the milligram amount tells you little.
Does it help inflammatory bowel disease?
Small studies have examined boswellia in ulcerative colitis and Crohn disease with inconclusive results.
These are conditions requiring specialist treatment, and anyone with them should discuss supplements with their gastroenterology team.
Who might it suit?
Someone with knee osteoarthritis already doing the exercise and weight management, looking for an additional option with reasonable evidence.
It is not a substitute for either.
How long before you judge it?
Four to eight weeks, matching the trial durations, with joint symptoms recorded rather than recalled.
Osteoarthritis symptoms fluctuate with activity and weather, which makes short assessments unreliable.
A simple weekly score is enough.
Who should avoid it?
Anyone pregnant or breastfeeding, and anyone on anticoagulants without checking first.
Boswellia is generally well tolerated in everyone else, with digestive effects the main complaint.
Taking it with food resolves most of those.